輸入代號或公司名稱後按 Enter
INFU

InfuSystem Holdings, Inc

+0.17 (+1.37%)前一交易日收盤 2026-09-17
美股 · NYSE · 醫療器材 · 外科與醫療器材SIC 3841
12.62USD68.5K成交股數251M市值31.6本益比(近四季)1.8股價營收比+2.6%營收年增(近四季)2026-11-03下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
營收36.9M+3%33.7M-3%36.2M+3%36.5M+8%36.0M+13%34.7M+9%35.3M+11%33.7M+6%32.0M31.8M31.9M31.7M
營業成本15.5M14.0M15.8M15.7M16.1M15.5M16.3M17.0M15.5M15.1M16.3M15.9M
毛利21.4M+8%19.7M+3%20.4M+7%20.8M+25%19.9M+21%19.2M+15%19.0M+22%16.7M+5%16.5M16.7M15.6M15.8M
毛利率58.0%58.4%56.4%57.1%55.2%55.2%53.9%49.5%51.5%52.6%48.9%49.9%
研發費用
銷售管理費用14.1M14.8M14.1M14.4M13.1M15.3M12.8M11.5M13.7M11.5M10.9M11.4M
營業利益4.2M+10%1.6M+157%3.7M+14%3.8M+105%3.8M-547%618K-51%3.3M+92%1.9M+49%−845K1.3M1.7M1.2M
營業利益率11.2%4.7%10.3%10.4%10.5%1.8%9.2%5.5%-2.6%3.9%5.3%3.9%
稅後淨利3.2M+24%1.0M-481%2.0M+13%2.3M+215%2.6M-334%−267K-471%1.8M+162%717K+65%−1.1M72K689K435K
淨利率8.7%3.0%5.6%6.2%7.2%-0.8%5.1%2.1%-3.5%0.2%2.2%1.4%
稀釋 EPS0.15+25%0.05-600%0.09+13%0.11+267%0.12-340%-0.01-200%0.08+167%0.03+50%-0.050.010.030.02
稀釋股數20.9M20.9M21.1M20.9M21.1M21.1M21.7M21.7M21.2M21.6M21.7M21.6M

資產負債表 期末餘額

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
現金與約當現金964K2.1M3.2M955K720K1.5M380K146K822K231K161K134K
應收帳款27.2M24.0M22.9M24.3M24.5M23.9M22.8M21.3M20.5M19.8M19.5M18.9M
存貨5.5M5.8M5.4M5.6M5.7M6.1M6.7M6.8M6.2M6.4M6.1M5.7M
總資產97.7M98.7M101M98.9M101M104M105M109M105M103M102M103M
有息負債20.4M19.6M19.6M20.9M26.3M28.7M28.0M34.2M29.9M29.1M32.7M36.1M
總負債38.6M39.9M43.2M43.4M46.3M49.1M49.8M55.0M52.6M50.6M50.6M52.8M
股東權益59.1M58.7M57.3M55.5M54.5M55.1M55.5M53.5M52.3M52.3M51.5M50.0M
負債比39.5%40.5%43.0%43.9%45.9%47.1%47.3%50.7%50.1%49.2%49.6%51.4%
淨現金(現金 − 有息負債)−19.5M−17.5M−16.4M−20.0M−25.6M−27.2M−27.6M−34.0M−29.1M−28.9M−32.5M−36.0M

現金流量表 單季

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
營業現金流970K-46%1.8M377K
資本支出157K131K182K
自由現金流813K-51%1.6M195K
折舊攤銷3.2M3.3M3.3M3.3M3.3M3.3M3.1M3.0M2.9M3.1M3.1M3.1M
買回庫藏股809K2.9M0.00
現金股利
自由現金流率2.4%4.7%0.6%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

業務分部2025 年度 · 151M
Patient Services86.5M57.4%+7.7%
Device Solutions64.1M42.6%+3.8%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY2025143M+6.4%6.6M4.6%0.3123.8M
FY2024135M+7.2%2.3M1.7%0.1119.4M
FY2023126M+14.4%872K0.7%0.0410.2M
FY2022110M+7.4%18K0.0%0.0016.5M
FY2021102M+5.1%1.4M1.4%0.0617.3M
FY202097.4M+20.1%17.3M17.8%0.8019.2M
FY201981.1M+20.8%1.4M1.7%0.0710.9M
FY201867.1M−1.1M-1.6%-0.0511.1M